Revisions for Nirmatrelvir/ritonavir (Paxlovid)

Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.

RevisionOperations
02-7-25 by ripal121

ripal121 replaced Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module.

current revision
02-7-25 by ripal121

ripal121 replaced Intermittent HD with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module.

02-7-25 by conan.macdougal...

[email protected] replaced For detailed view of dialysis dosing and evidence, see <a href="https://idmp.ucsfsitebuilder.acsitefactory.com/content/ucsf-adult-antimicrobial-dosing-dialysis-reference-document">Dosing in Hemodialysis</a> document.</p> with via Scanner Search and Replace module.

11-4-24 by [email protected]
07-16-24 by ripal121
08-31-23 by ripal121
04-25-23 by kaipe

Updated to display "restricted" status at UCSF

06-13-22 by conan.macdougal...

Dosing: Adult Antimicrobial Dosing, Non-dialysis

Indication CrCl >60 mL/min 30-60 mL/min <30 mL/min
All Indications 300/100 mg PO BID 150/100 mg PO BID Not recommended

Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis

Indication

Intermittent Hemodialysis

Continuous Hemodialysis
All Indications No data No data

Dialysis Notes

Review medications for potential drug interactions.

Restricted to ASP or ID consult service (with exceptions):

- Inpatients (or those in the ED pending admission) with mild-moderate COVID-19 with symptom onset within 5 days and high-risk for progression who are admitted for reasons other than COVID-19 (see CDC Website for high-risk criteria)

References: